Related references
Note: Only part of the references are listed.Cooperative Blockade of PKCα and JAK2 Drives Apoptosis in Glioblastoma
Robyn A. Wong et al.
CANCER RESEARCH (2020)
Metabolomic study of natrin-induced apoptosis in SMMC-7721 hepatocellular carcinoma cells by ultra-performance liquid chromatography-quadrupole/time-of-flight mass spectrometry
Shiyin Lu et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2019)
mTOR Signaling in Cancer and mTOR Inhibitors in Solid Tumor Targeting Therapy
Tian Tian et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Enhanced phosphatidylserine-selective cancer therapy with irradiation and SapC-DOPS nanovesicles
Harold W. Davis et al.
Oncotarget (2019)
Metabolic and lipidomic investigation of the antiproliferative effects of coronatine against human melanoma cells
Hye-Youn Kim et al.
SCIENTIFIC REPORTS (2019)
Unique Roles of Sphingolipids in Selected Malignant and Nonmalignant Lesions of Female Reproductive System
Pawel Knapp et al.
BIOMED RESEARCH INTERNATIONAL (2019)
Understanding the effect of repeated administration of meloxicam on feline renal cortex and medulla: A lipidomics and metabolomics approach
Sol M. Rivera-Velez et al.
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS (2019)
Lactate in the Regulation of Tumor Microenvironment and Therapeutic Approaches
Karen G. de la Cruz-Lopez et al.
FRONTIERS IN ONCOLOGY (2019)
3D Growth of Cancer Cells Elicits Sensitivity to Kinase Inhibitors but Not Lipid Metabolism Modifiers
Dylan T. Jones et al.
MOLECULAR CANCER THERAPEUTICS (2019)
Acetyl-L-carnitine is an anti-angiogenic agent targeting the VEGFR2 and CXCR4 pathways
Denisa Baci et al.
CANCER LETTERS (2018)
Metabolomics and Lipidomics Study of Mouse Models of Type 1 Diabetes Highlights Divergent Metabolism in Purine and Tryptophan Metabolism Prior to Disease Onset
Steven A. Murfitt et al.
JOURNAL OF PROTEOME RESEARCH (2018)
PP242 Counteracts Glioblastoma Cell Proliferation, Migration, Invasiveness and Stemness Properties by Inhibiting mTORC2/AKT
Carmen Mecca et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2018)
The carnitine system and cancer metabolic plasticity
Mariarosa Anna Beatrice Melone et al.
CELL DEATH & DISEASE (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Multiplatform plasma metabolic and lipid fingerprinting of breast cancer: A pilot control-case study in Colombian Hispanic women
Monica P. Cala et al.
PLOS ONE (2018)
Sphingolipid metabolism in cancer signalling and therapy
Besim Ogretmen
NATURE REVIEWS CANCER (2018)
GPR55 receptor antagonist decreases glycolytic activity in PANC-1 pancreatic cancer cell line and tumor xenografts
Michel Bernier et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Ethanolamine and Phosphatidylethanolamine: Partners in Health and Disease
Dhaval Patel et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2017)
Peiminine inhibits colorectal cancer cell proliferation by inducing apoptosis and autophagy and modulating key metabolic pathways
Zhi Zheng et al.
ONCOTARGET (2017)
Targeting Membrane Lipid a Potential Cancer Cure?
Loh Teng-Hern Tan et al.
FRONTIERS IN PHARMACOLOGY (2017)
PP242 suppresses bladder cancer cell proliferation and migration through deactivating the mammalian target of rapamycin complex 2/AKT1 signaling pathway
Zhe Zhang et al.
MOLECULAR MEDICINE REPORTS (2016)
Glutaminolysis as a target for cancer therapy
L. Jin et al.
ONCOGENE (2016)
Metabolomics study on the antitumor effect of marine natural compound flexibilide in HCT-116 colon cancer cell line
Dan Gao et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2016)
Monitoring cancer prognosis, diagnosis and treatment efficacy using metabolomics and lipidomics
Emily G. Armitage et al.
METABOLOMICS (2016)
Fatty acid oxidation and carnitine palmitoyltransferase I: emerging therapeutic targets in cancer
Q. Qu et al.
CELL DEATH & DISEASE (2016)
Targeting Phospholipid Metabolism in Cancer
Menglin Cheng et al.
FRONTIERS IN ONCOLOGY (2016)
Reprogramming glucose metabolism in cancer: can it be exploited for cancer therapy?
Nissim Hay
NATURE REVIEWS CANCER (2016)
Compensatory glutamine metabolism promotes glioblastoma resistance to mTOR inhibitor treatment
Kazuhiro Tanaka et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Phosphatidylcholine's functions beyond that of a membrane brick
Samuel Furse et al.
MOLECULAR MEMBRANE BIOLOGY (2015)
Combination of cetuximab and PP242 synergistically suppress the progression of wild-type KRAS colorectal carcinoma
Lei Cheng et al.
ONCOTARGETS AND THERAPY (2015)
Variation in human cancer cell external phosphatidylserine is regulated by flippase activity and intracellular calcium
Subrahmanya D. Vallabhapurapu et al.
ONCOTARGET (2015)
PP242 suppresses cell proliferation, metastasis, and angiogenesis of gastric cancer through inhibition of the PI3K/AKT/mTOR pathway
Xiaofang Xing et al.
ANTI-CANCER DRUGS (2014)
Targeting mTOR network in colorectal cancer therapy
Xiao-Wen Wang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
mTOR pathway in colorectal cancer: an update
Maria Giovanna Francipane et al.
ONCOTARGET (2014)
Accumulated phosphatidylcholine (16:0/16:1) in human colorectal cancer; possible involvement of LPCAT4
Nobuya Kurabe et al.
CANCER SCIENCE (2013)
mTOR is a key modulator of ageing and age-related disease
Simon C. Johnson et al.
NATURE (2013)
Targeting of mTORC1/2 by the mTOR kinase inhibitor PP242 induces apoptosis in AML cells under conditions mimicking the bone marrow microenvironment
Zhihong Zeng et al.
BLOOD (2012)
Antitumor activities of ATP-competitive inhibitors of mTOR in colon cancer cells
Benjamin Blaser et al.
BMC CANCER (2012)
mTOR Signaling in Growth Control and Disease
Mathieu Laplante et al.
CELL (2012)
Cell metabolism: An essential link between cell growth and apoptosis
Emily F. Mason et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2011)
Lactate enhances motility of tumor cells and inhibits monocyte migration and cytokine release
Kristina Goetze et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2011)
Increased Exposure of Phosphatidylethanolamine on the Surface of Tumor Vascular Endothelium
Jason H. Stafford et al.
NEOPLASIA (2011)
The Kennedy Pathway-De Novo Synthesis of Phosphatidylethanolamine and Phosphatidylcholine
Federica Gibellini et al.
IUBMB LIFE (2010)
Phosphoinositides: lipid regulators of membrane proteins
Bjoern H. Falkenburger et al.
JOURNAL OF PHYSIOLOGY-LONDON (2010)
Targeting mTORC2 inhibits colon cancer cell proliferation in vitro and tumor formation in vivo
Didier Roulin et al.
MOLECULAR CANCER (2010)
Effective and selective targeting of leukemia cells using a TORC1/2 kinase inhibitor
Matthew R. Janes et al.
NATURE MEDICINE (2010)
mTOR Signaling Pathway Is a Target for the Treatment of Colorectal Cancer
Yan-Jie Zhang et al.
ANNALS OF SURGICAL ONCOLOGY (2009)
Targeted Inhibition of Mammalian Target of Rapamycin Signaling Inhibits Tumorigenesis of Colorectal Cancer
Pat Gulhati et al.
CLINICAL CANCER RESEARCH (2009)
Serum Metabolite Profiling of Human Colorectal Cancer Using GC-TOFMS and UPLC-QTOFMS
Yunping Qiu et al.
JOURNAL OF PROTEOME RESEARCH (2009)
Principles of bioactive lipid signalling: lessons from sphingolipids
Yusuf A. Hannun et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
Targeting mammalian target of rapamycin (mTOR) for health and diseases
Chi Kwan Tsang et al.
DRUG DISCOVERY TODAY (2007)
Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB
DD Sarbassov et al.
MOLECULAR CELL (2006)
Phosphatidylcholine and cell death
Z Cui et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2002)
Lysophosphatidylcholine induces apoptosis in human endothelial cells through a p38-mitogen-activated protein kinase-dependent mechanism
M Takahashi et al.
ATHEROSCLEROSIS (2002)
Cytostatic effect of inostamycin, an inhibitor of cytidine 5 '-diphosphate 1,2-diacyl-sn-glycerol (CDP-DG): Inositol transferase, on oral squamous cell carcinoma cell lines
Y Baba et al.
CELL BIOLOGY INTERNATIONAL (2001)